SEOUL (Reuters) – South Korea’s drug safety ministry on Wednesday said it will approve use of AstraZeneca PLC’s COVID-19 vaccine for all people, including those aged 65 and over.
The AstraZeneca shot, co-developed by Britain’s Oxford University, is the first vaccine to be granted approval in the country.
(Reporting by Sangmi Cha; Editing by Christopher Cushing)
